Back
Edgewise Therapeutics Stock Price Chart
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here
Sell
48
EWTX
Edgewise Therapeutics
Last Price:
$30.09
Seasonality Move:
26.98%
7 Day Trial
ALL ACCESS PASS
$
7
Elon Musk Predicts MAJOR Crisis in Trump's First Year
See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.-
The current trend is relatively stagnant and EWTX is experiencing slight selling pressure.
Edgewise Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 30 | Buy |
| 20-day SMA: | 31.04 | Sell |
| 50-day SMA: | 32.69 | Sell |
| 200-day SMA: | 22.37 | Buy |
| 8-day EMA: | 30.45 | Buy |
| 20-day EMA: | 30.95 | Sell |
| 50-day EMA: | 30.6 | Buy |
| 200-day EMA: | 23.56 | Buy |
Edgewise Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.54 | Sell |
| Relative Strength Index (14 RSI): | 48.43 | Sell |
| Chaikin Money Flow: | -518268 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (29.8 - 32.48) | Sell |
| Bollinger Bands (100): | (19.78 - 33.66) | Buy |
Edgewise Therapeutics Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Edgewise Therapeutics Stock
Is Edgewise Therapeutics Stock a Buy?
-
Edgewise Therapeutics share price is 30.74 while EWTX 8-day simple moving average is 30.00, which is a Buy signal.
-
The stock price of EWTX is 30.74 while Edgewise Therapeutics 20-day SMA is 31.04, which makes it a Sell.
-
Edgewise Therapeutics 50-day simple moving average is 32.69 while EWTX share price is 30.74, making it a Sell technically.
-
EWTX stock price is 30.74 and Edgewise Therapeutics 200-day simple moving average is 22.37, creating a Buy signal.
EWTX Technical Analysis vs Fundamental Analysis
Sell
48
Edgewise Therapeutics (EWTX)
is a Sell
Is Edgewise Therapeutics a Buy or a Sell?
-
Edgewise Therapeutics stock is rated a SellThe current Edgewise Therapeutics [EWTX] share price is $30.74. The Score for EWTX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
Edgewise Therapeutics Stock Info
Market Cap:
2.9B
Price in USD:
30.74
Share Volume:
1.1M
Edgewise Therapeutics 52-Week Range
52-Week High:
38.12
52-Week Low:
9.00
Sell
48
Edgewise Therapeutics (EWTX)
is a Sell
Edgewise Therapeutics Share Price Forecast
-
What is the Edgewise Therapeutics stock price today?The Edgewise Therapeutics stock price is 30.74 USD today.
-
Will EWTX stock go up or go down?Edgewise Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Edgewise Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Edgewise Therapeutics is overvalued.
Is Edgewise Therapeutics Stock a Buy?
-
Edgewise Therapeutics share price is 30.74 while EWTX 8-day exponential moving average is 30.45, which is a Buy signal.
-
The stock price of EWTX is 30.74 while Edgewise Therapeutics 20-day EMA is 30.95, which makes it a Sell.
-
Edgewise Therapeutics 50-day exponential moving average is 30.60 while EWTX share price is 30.74, making it a Buy technically.
-
EWTX stock price is 30.74 and Edgewise Therapeutics 200-day simple moving average is 23.56, creating a Buy signal.
Fundamental Analysis of Edgewise Therapeutics
Is Edgewise Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.04 per share, and a decrease next year of $0.30 per share.
Technical Analysis of Edgewise Therapeutics
Should I short Edgewise Therapeutics stock?
-
EWTX Moving Average Covergence Divergence (MACD) indicator is -0.54, suggesting Edgewise Therapeutics is a Sell
-
Edgewise Therapeutics Relative Strength Index (RSI) is 48.43, which suggest Edgewise Therapeutics is oversold
-
The Bollinger Bands (25) for Edgewise Therapeutics is (29.8 - 32.48), which suggest Edgewise Therapeutics is a Buy
-
The Bollinger Bands (100) for Edgewise Therapeutics is (19.78 - 33.66), which suggest Edgewise Therapeutics is a Buy
* Edgewise Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.